Tracheal Cancer

Overview

4.5 out of 5 (6 Reviews)

Credits

1.00

Pharmacology Credits

0.5

Post Assessment Questions

5

Start Date

1 Sep 2023

Last Review Date

1 Sep 2023

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Primary tracheal tumors are uncommon but usually malignant in adults, accounting for about 0.2 % of all malignant tumors. The estimated incidence of tracheal cancers is about 0.1 per 100,000 people per year. The largest report of primary tracheal tumors is based on the Surveillance, Epidemiology, and End Results (SEER) database study of 578 cases. In this analysis, 55% were men, and the major histological type was squamous cell carcinoma, accounting for 45% of the cases. Other histologic types include adenoid cystic carcinoma, small cell carcinoma, large cell carcinoma, sarcoma, adenocarcinoma, and carcinoma not otherwise specified or undifferentiated type. This activity describes the cause, pathophysiology, presentation, and diagnosis of tracheal cancer and highlights the role of the interprofessional team in its management.

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify the etiology of tracheal cancer.
  • Describe the evaluation of a patient with tracheal cancer.
  • Outline the management options available for tracheal cancer.
  • Explore modalities to improve care coordination among interprofessional team members to improve outcomes for patients affected by tracheal cancer.
  • Outline the pharmacologic therapy as it applies to Tracheal Cancer

Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Nurse Practitioners: StatPearls designates this activity for 1.00 ANCC contact hour(s), which includes 0.5 hour(s) of pharmacology. NPs should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

DIMITRIOS T. on 1/24/2022

Paul H. on 6/3/2022

M A. on 8/23/2022

Karl S. on 12/31/2022

Karl S. on 1/7/2023

Great review.

Richard P. on 12/24/2023

Unlimited Nurse Practitioner CE

Stay up to date on the latest medical knowledge with 6684 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7941 hours of CE.

Single Activity

Take this single activity

$49 1 activity

6 Month Unlimited Nurse Practitioner CE

Access to all the Unlimited Nurse Practitioner CE activities in all specialties.

$379 per half year per user

1 Year Unlimited Nurse Practitioner CE

Access to all the Unlimited Nurse Practitioner CE activities in all specialties.

$579 per 1 year per user